Clinical trial
The Initial Double-Blind Drug-Eluting Stent vs Bare-Metal Stent Study.
NCT00233805 · Cordis US Corp., Industry · Completed
Key facts
| NCT number | NCT00233805 |
|---|---|
| Title | The Initial Double-Blind Drug-Eluting Stent vs Bare-Metal Stent Study. |
| Official title | A Randomized Study With the Sirolimus Coated Modified BX Velocity Balloon-Expandable Stent in the Treatment of Patients With de Novo Native Coronary Artery Lesions |
| Acronym | RAVEL |
| Lead sponsor | Cordis US Corp., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Device |
| Interventions | Sirolimus coated Bx Velocity™, Bare metal Bx Velocity™ |
| Enrollment | 220 |
| Start date | Aug 1, 2000 |
| Completion | Dec 1, 2007 |
| First posted | Oct 6, 2005 |
| Last update posted | Aug 6, 2008 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: